Apr 10, 2020

Added questions to “Psychotropic Drug Classes, MOA, and Names (Level 2)”. Merged broad-review tests “Epidemiology” and “Psychiatric DDx, Comorbidities, & Complications” together. Merged “Psychotropic Drug Classes, MOA, and Names (Level 2)”, “Psychotropic Drug Indications, Contraindications, Side Effects, and DDI”, and “Psychotropic Drug Dosing” together into “Psychopharmacology”.